Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The licensed protease inhibitors are:
amprenavir (Agenerase)
atazanavir (Reyataz)
darunavir (Prezista)
fosamprenavir (Telzir, Lexiva)
indinavir (Crixivan)
lopinavir/ritonavir (Kaletra, Aluvia)
nelfinavir (Viracept)
ritonavir (Norvir)
saquinavir (Invirase)*
tipranavir (Aptivus).
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi